MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $341,054 | -53.5% | 1,474 | -53.5% | 0.00% | -66.7% |
| Q2 2023 | $732,963 | +6008.0% | 3,173 | +1734.1% | 0.00% | – |
| Q2 2022 | $12,000 | -29.4% | 173 | +0.6% | 0.00% | – |
| Q1 2022 | $17,000 | +54.5% | 172 | +35.4% | 0.00% | – |
| Q4 2021 | $11,000 | +10.0% | 127 | +2.4% | 0.00% | – |
| Q3 2021 | $10,000 | -23.1% | 124 | -8.1% | 0.00% | – |
| Q2 2021 | $13,000 | +8.3% | 135 | +33.7% | 0.00% | – |
| Q1 2021 | $12,000 | +9.1% | 101 | +4.1% | 0.00% | – |
| Q4 2020 | $11,000 | -94.4% | 97 | -94.1% | 0.00% | -100.0% |
| Q3 2020 | $195,000 | +12.1% | 1,651 | +6.2% | 0.00% | 0.0% |
| Q2 2020 | $174,000 | +85.1% | 1,554 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $94,000 | -29.9% | 1,554 | 0.0% | 0.00% | -60.0% |
| Q3 2019 | $134,000 | -17.8% | 1,554 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $163,000 | +3975.0% | 1,554 | +3690.2% | 0.01% | – |
| Q1 2018 | $4,000 | -55.6% | 41 | -58.2% | 0.00% | -100.0% |
| Q4 2017 | $9,000 | – | 98 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
| Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
| Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
| AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
| Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
| Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
| Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
| Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
| Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
| TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |